Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines

Jefremow A, Wiesmüller M, Rouse RA, Dietrich P, Kremer A, Waldner M, Neurath M, Siebler J (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Oncology Research and Treatment Karger Publishers

Publisher: KARGER

City/Town: BASEL

Pages Range: 216-216

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Marco Wiesmüller Lehrstuhl für Klinische Nuklearmedizin Peter Dietrich Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Andreas Kremer Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology Maximilian Waldner Professur für Funktionelle Bildgebung in der Medizin Markus Neurath Lehrstuhl für Innere Medizin I Jürgen Siebler Professur für Hepatologie

How to cite

APA:

Jefremow, A., Wiesmüller, M., Rouse, R.A., Dietrich, P., Kremer, A., Waldner, M.,... Siebler, J. (2020). Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines. In ONCOLOGY RESEARCH AND TREATMENT (pp. 216-216). BASEL: KARGER.

MLA:

Jefremow, Andre, et al. "Efficiency and Toxicity of Lenvatinib in Advanced HCC in Later Treatment Lines." Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2020. 216-216.

BibTeX: Download